HDAC9 and lung carcinoma: In our previous study, we proposed a novel, precise synthesis method for PsA and its analogs and investigated that a β-naphthyl substituted homodimeric analog PsA-111 exhibits HDAC inhibitory activity in lung cancer cells [17].